Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Leukemia ; 27(3): 661-70, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22910183

RESUMEN

The haematopoietic system is prone to age-related disorders ranging from deficits in functional blood cells to the development of neoplastic states. Such neoplasms often involve recurrent cytogenetic abnormalities, among which a deletion in the long arm of chromosome 20 (del20q) is common in myeloid malignancies. The del20q minimum deleted region contains nine genes, including MYBL2, which encodes a key protein involved in the maintenance of genome integrity. Here, we show that mice expressing half the normal levels of Mybl2 (Mybl2(+/Δ)) develop a variety of myeloid disorders upon ageing. These include myeloproliferative neoplasms, myelodysplasia (MDS) and myeloid leukaemia, mirroring the human conditions associated with del20q. Moreover, analysis of gene expression profiles from patients with MDS demonstrated reduced levels of MYBL2, regardless of del20q status and demonstrated a strong correlation between low levels of MYBL2 RNA and reduced expression of a subset of genes related to DNA replication and checkpoint control pathways. Paralleling the human data, we found that these pathways are also disturbed in our Mybl2(+/Δ) mice. This novel mouse model, therefore, represents a valuable tool for studying the initiation and progression of haematological malignancies during ageing, and may provide a platform for preclinical testing of therapeutic approaches.


Asunto(s)
Apoptosis , Proteínas de Ciclo Celular/metabolismo , Proteínas de Ciclo Celular/fisiología , Predisposición Genética a la Enfermedad , Neoplasias Hematológicas/etiología , Transactivadores/metabolismo , Transactivadores/fisiología , Factores de Edad , Animales , Western Blotting , Trasplante de Médula Ósea , Estudios de Casos y Controles , Proteínas de Ciclo Celular/genética , Proliferación Celular , Progresión de la Enfermedad , Citometría de Flujo , Neoplasias Hematológicas/patología , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transactivadores/genética
2.
Oncogene ; 32(32): 3744-53, 2013 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-22945645

RESUMEN

It has become increasingly clear that oncogenes not only provide aberrant growth signals to cells but also cause DNA damage at replication forks (replication stress), which activate the ataxia telangiectasia mutated (ATM)/p53-dependent tumor barrier. Here we studied underlying mechanisms of oncogene-induced replication stress in cells overexpressing the oncogene Cyclin E. Cyclin E overexpression is associated with increased firing of replication origins, impaired replication fork progression and DNA damage that activates RAD51-mediated recombination. By inhibiting replication initiation factors, we show that Cyclin E-induced replication slowing and DNA damage is a consequence of excessive origin firing. A significant amount of Cyclin E-induced replication slowing is due to interference between replication and transcription, which also underlies the activation of homologous recombination. Our data suggest that Cyclin E-induced replication stress is caused by deregulation of replication initiation and increased interference between replication and transcription, which results in impaired replication fork progression and DNA damage triggering the tumor barrier or cancer-promoting mutations.


Asunto(s)
Ciclina E/fisiología , Replicación del ADN , Transcripción Genética , Línea Celular Tumoral , Daño del ADN , Recombinación Homóloga , Humanos , Oncogenes , Recombinasa Rad51/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA